Drugs / MCAM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07602335 | Aug 2026 → Jun 2027 expected | substance-related disorder | The University of Texas Health Science Center at San Antonio | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MCAM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07602335 ↗ |
| Route | Oral | “MCAM will be dosed orally” NCT07602335 ↗ |